Product Images Remifentanil Hydrochloride
View Photos of Packaging, Labels & Appearance
- carton label-1mg per vial.jpg - carton label 1mg per vial
- carton label-2mg per vial.jpg - carton label 2mg per vial
- carton label-5mg per vial.jpg - carton label 5mg per vial
- Chemical Structure - chemical stracture
- container label-1mg per vial.jpg - container label 1mg per vial
- container label-2mg per vial.jpg - container label 2mg per vial
- container label-5mg per vial.jpg - container label 5mg per vial
- figure 1.jpg - figure 1
- figure 2.jpg - figure 2
Product Label Images
The following 9 images provide visual information about the product associated with Remifentanil Hydrochloride NDC 75834-231 by Nivagen Pharmaceuticals, Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
carton label-2mg per vial.jpg - carton label 2mg per vial

This is a label for Remifentanil Hydrochloride for Injection, to be used intravenously. The product is in single-dose vials and should only be administered as per prescription information. It provides details on dilution instructions, dosages, and storage conditions. The manufacturer is Nivagen Pharmaceutical. It is important to discard any unused portion of the drug.*
carton label-5mg per vial.jpg - carton label 5mg per vial

This is an information sheet for Remifentanil Hydrochloride injection, containing details such as dosage, reconstitution instructions, storage guidelines, and manufacturer information. It is intended for intravenous use only and comes in single-dose vials. The text also includes important warnings about dilution and administration procedure. The barcode suggests modern inventory management practices may be implemented for tracking.*
container label-1mg per vial.jpg - container label 1mg per vial

This text describes a medication with the NDC number 75834-230-01, which is Remifentanil Hydrochloride for Injection. Each vial contains 1 mg of the medication, and it is intended for intravenous use only. The medication is sterile and must be reconstituted and diluted before use. The usual dosage information can be found in the insert provided with the medication. Any unused portion should be discarded. The medication is manufactured by Nivagen Pharmaceuticals, Inc. in Sacramento, CA, USA. The revision date of production is February 2022.*
container label-5mg per vial.jpg - container label 5mg per vial

This is a pharmaceutical label for a sterile product that requires reconstitution and dilution before use. The medication is Hydrochloride with a usual dosage described in the insert. It is manufactured for Nivagen Pharmaceuticals, Inc. with a strength of 5 mg per vial. The product is for intravenous use only and is a single-dose vial. It has a batch number and an expiration date for tracking purposes.*
figure 1.jpg - figure 1

This text provides information related to Minute Ventilation expressed as a percentage of baseline. It includes data points for two substances: Remifentanil Hydrochloride and Alfentanil, with 11 and 10 subjects respectively. The timeline spans over 270 minutes, showing the post-infusion effects of the substances over time.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.